Osiris Therapeutics, Inc. , announced today that the manuscript from its multi-center , randomized, controlled clinical trial comparing the safety and effectiveness of GrafixA to control in patients with chronic diabetic foot ulcers , which was accepted for publication in the International Wound Journal , is now available online and will also be in ... (more)
http://ift.tt/WyMwxV
http://ift.tt/WyMwxV
No comments:
Post a Comment